SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-21-056614
Filing Date
2021-04-28
Accepted
2021-04-28 16:55:14
Documents
4
Period of Report
2021-06-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm212504-1_def14a.htm DEF 14A 1153226
2 GRAPHIC tm212504d1_fc-payout4c.jpg GRAPHIC 29453
3 GRAPHIC tm212504d1-proxy_1idera4c.jpg GRAPHIC 837065
4 GRAPHIC tm212504d1-proxy_2idera4c.jpg GRAPHIC 667847
  Complete submission text file 0001104659-21-056614.txt   3267825
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-31918 | Film No.: 21865090
SIC: 2836 Biological Products, (No Diagnostic Substances)